Approval · Notice of Compliance 25926 · 2021
XYLOCARD: Notice of Compliance 25926
Issued May 26, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25926
- Date
- May 26, 2021
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to ensure consistent with international labelling
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XYLOCARD | Not yet assigned | — |
Medicinal ingredients
- LIDOCAINE HYDROCHLORIDE 20 MG per ML